HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49658,
"recordsTotal": 49658,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-days_late&start=49500",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-days_late&start=48900",
"results": [
{
"registry_id": "NCT07214467",
"publication_url": "https://clinicaltrials.gov/study/NCT07214467",
"title": "Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2031-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06549595",
"publication_url": "https://clinicaltrials.gov/study/NCT06549595",
"title": "A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2031-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156398",
"publication_url": "https://clinicaltrials.gov/study/NCT05156398",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age",
"has_exemption": false,
"start_date": "2022-02-28",
"completion_date": "2031-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05461170",
"publication_url": "https://clinicaltrials.gov/study/NCT05461170",
"title": "A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants With Chronic Hepatitis D Virus Infection (SOLSTICE)",
"has_exemption": false,
"start_date": "2022-09-17",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vir Biotechnology, Inc.",
"sponsor_slug": "vir-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06511453",
"publication_url": "https://clinicaltrials.gov/study/NCT06511453",
"title": "Remote Self-Administered Acupressure for Pain Management in Patients With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969430",
"publication_url": "https://clinicaltrials.gov/study/NCT06969430",
"title": "A Phase 1/2, First-in-human, Multicenter, Open-label Trial Evaluating the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007312",
"publication_url": "https://clinicaltrials.gov/study/NCT07007312",
"title": "Phase 3 Randomized, Double-blind, Placebo-controlled Studies Assessing Ziftomenib in Combination With Either Standard of Care Nonintensive (Venetoclax+Azacitidine) or Intensive (7+3) Therapy in Patients With Untreated NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285239",
"publication_url": "https://clinicaltrials.gov/study/NCT07285239",
"title": "Randomized Phase 3 Trial of Belantamab Mafodotin or Daratumumab in Combination With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PrECOG, LLC.",
"sponsor_slug": "precog-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07717736",
"publication_url": "https://clinicaltrials.gov/study/NCT07717736",
"title": "Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abeona Therapeutics, Inc",
"sponsor_slug": "abeona-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813014",
"publication_url": "https://clinicaltrials.gov/study/NCT06813014",
"title": "Sitagliptin's Effects on Glucose-stimulated Insulin Secretion and Oral Glucose",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2031-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145010",
"publication_url": "https://clinicaltrials.gov/study/NCT05145010",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL OLE",
"has_exemption": false,
"start_date": "2021-12-06",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, a BridgeBio company",
"sponsor_slug": "qed-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851754",
"publication_url": "https://clinicaltrials.gov/study/NCT06851754",
"title": "Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",
"sponsor_slug": "eunice-kennedy-shriver-national-institute-of-child-health-and-human-development-nichd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145309",
"publication_url": "https://clinicaltrials.gov/study/NCT05145309",
"title": "Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans",
"has_exemption": false,
"start_date": "2026-11-15",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225972",
"publication_url": "https://clinicaltrials.gov/study/NCT07225972",
"title": "An Open-Label Prospective Randomized Trial of Family Donor-Derived ADV or CMV CTLs Plus Standard of Care (SOC) vs SOC Alone in Children, Adolescents and Young Adults Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Refractory ADV or CMV Infection/Viremia",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07587593",
"publication_url": "https://clinicaltrials.gov/study/NCT07587593",
"title": "Comparative Effectiveness of Interventions to Prevent Infections and Other Complications Arising From Central Venous Access Devices: the IVCare Adaptive Platform Trial.",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Queensland",
"sponsor_slug": "the-university-of-queensland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720180",
"publication_url": "https://clinicaltrials.gov/study/NCT07720180",
"title": "OVAFIT-TIL: A Phase Ib Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab in Recurrent Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389239",
"publication_url": "https://clinicaltrials.gov/study/NCT07389239",
"title": "A Phase I/IIA Study Evaluating the Safety and Efficacy of NY-ESO-1TCR/dnTGFBRII Engineered T Cells in Combination With Decitabine in Subjects With Recurrent or Treatment Refractory Ovarian Cancer and Other Advanced Malignancies",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2031-12-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06663332",
"publication_url": "https://clinicaltrials.gov/study/NCT06663332",
"title": "CNTO1959ISD3001: A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study to Evaluate the Safety of Guselkumab in Pediatric Participants With Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2031-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02128906",
"publication_url": "https://clinicaltrials.gov/study/NCT02128906",
"title": "A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design",
"has_exemption": false,
"start_date": "2013-12-23",
"completion_date": "2031-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Wilke",
"sponsor_slug": "christopher-wilke",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06632444",
"publication_url": "https://clinicaltrials.gov/study/NCT06632444",
"title": "A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase III Trial Evaluating Long-term Efficacy and Safety of Survodutide Weekly Injections in Adult Participants With Noncirrhotic Non-alcoholic Steatohepatitis/Metabolic Dysfunction-associated Steatohepatitis (NASH/MASH) and (F2) - (F3) Stage of Liver Fibrosis",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2031-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04580420",
"publication_url": "https://clinicaltrials.gov/study/NCT04580420",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis",
"has_exemption": false,
"start_date": "2021-04-15",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06620302",
"publication_url": "https://clinicaltrials.gov/study/NCT06620302",
"title": "DT2216 in Combination With Irinotecan for Children, Adolescents and Young Adults With Relapsed or Refractory Solid Tumors: A Phase I Study With Phase II Feasibility Cohort for Fibrolamellar Carcinoma",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680790",
"publication_url": "https://clinicaltrials.gov/study/NCT07680790",
"title": "A Phase III, Randomized, Open-label Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy as First-Line Therapy in Patients With EGFR-Mutant Locally Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2031-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01524211",
"publication_url": "https://clinicaltrials.gov/study/NCT01524211",
"title": "Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms",
"has_exemption": false,
"start_date": "2012-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01893307",
"publication_url": "https://clinicaltrials.gov/study/NCT01893307",
"title": "Phase III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck",
"has_exemption": false,
"start_date": "2013-08-26",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02579967",
"publication_url": "https://clinicaltrials.gov/study/NCT02579967",
"title": "Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies",
"has_exemption": false,
"start_date": "2015-11-19",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03984643",
"publication_url": "https://clinicaltrials.gov/study/NCT03984643",
"title": "Algorithms for Programming DBS Systems for ET",
"has_exemption": false,
"start_date": "2019-10-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04586166",
"publication_url": "https://clinicaltrials.gov/study/NCT04586166",
"title": "SASS: Randomized Trial of Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for Concomitant Management of Stress Urinary Incontinence During Minimally Invasive Sacrocolpopexy",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04124341",
"publication_url": "https://clinicaltrials.gov/study/NCT04124341",
"title": "Prefrontal Cortical Stimulation (PCS) for Severe Treatment Resistant Depression",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05478304",
"publication_url": "https://clinicaltrials.gov/study/NCT05478304",
"title": "Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AtriCure, Inc.",
"sponsor_slug": "atricure-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134232",
"publication_url": "https://clinicaltrials.gov/study/NCT06134232",
"title": "An Open -Label, Multicenter Study of Subjects With Metastatic Castrate-Resistant Prostate Cancer Treated With PROVENGE ® and Boosted With A Single Infusion of Sipuleucel-T to Measure Immune Response",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dendreon",
"sponsor_slug": "dendreon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428721",
"publication_url": "https://clinicaltrials.gov/study/NCT06428721",
"title": "The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population",
"has_exemption": false,
"start_date": "2024-03-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wright State University",
"sponsor_slug": "wright-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483100",
"publication_url": "https://clinicaltrials.gov/study/NCT06483100",
"title": "Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529809",
"publication_url": "https://clinicaltrials.gov/study/NCT06529809",
"title": "Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06390956",
"publication_url": "https://clinicaltrials.gov/study/NCT06390956",
"title": "A Phase II Study of Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951217",
"publication_url": "https://clinicaltrials.gov/study/NCT06951217",
"title": "A Multinational, Long-Term, Safety and Tolerability, Open-Label Extension Study of Subjects Who Have Participated in Avalyn Pharma Studies of Inhaled Antifibrotic Agents (AP-LTE-008 [SAIL])",
"has_exemption": false,
"start_date": "2025-04-17",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avalyn Pharma Inc.",
"sponsor_slug": "avalyn-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114874",
"publication_url": "https://clinicaltrials.gov/study/NCT07114874",
"title": "A Global, Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070115",
"publication_url": "https://clinicaltrials.gov/study/NCT07070115",
"title": "A Prospective Study Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® Reinforced Tissue Matrix",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tela Bio Inc",
"sponsor_slug": "tela-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005102",
"publication_url": "https://clinicaltrials.gov/study/NCT07005102",
"title": "A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-08-03",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276438",
"publication_url": "https://clinicaltrials.gov/study/NCT07276438",
"title": "MRI- or CT-Guidance and Online Adaptation With Stereotactic Radiotherapy for Prostate Cancer (MANTICORE)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195591",
"publication_url": "https://clinicaltrials.gov/study/NCT07195591",
"title": "Randomized Study of Resection and GammaTile® Followed by Concurrent External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ Versus Standard of Care in Newly Diagnosed Glioblastoma (GBM)",
"has_exemption": false,
"start_date": "2025-12-10",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GT Medical Technologies, Inc.",
"sponsor_slug": "gt-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07554521",
"publication_url": "https://clinicaltrials.gov/study/NCT07554521",
"title": "An Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Tislelizumab Plus Chemotherapy in a First-Line Setting for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in US Racial and Ethnic Minority Patients",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07513623",
"publication_url": "https://clinicaltrials.gov/study/NCT07513623",
"title": "Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06694454",
"publication_url": "https://clinicaltrials.gov/study/NCT06694454",
"title": "Phase I/II Study of Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07667296",
"publication_url": "https://clinicaltrials.gov/study/NCT07667296",
"title": "A Multicenter, Randomized, Open-Label Phase 3 Study of APG-157 as Neoadjuvant Therapy or as Induction and Maintenance Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aveta Biomics, Inc.",
"sponsor_slug": "aveta-biomics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07001254",
"publication_url": "https://clinicaltrials.gov/study/NCT07001254",
"title": "Phase II Open-label Clinical Trial Evaluating Efficacy of Romiplostim Added to Standard of Care for Children and Young Adults With Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Anjali Sharathkumar",
"sponsor_slug": "anjali-sharathkumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07705282",
"publication_url": "https://clinicaltrials.gov/study/NCT07705282",
"title": "Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Region Skane",
"sponsor_slug": "region-skane",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07542756",
"publication_url": "https://clinicaltrials.gov/study/NCT07542756",
"title": "Sequential Multiple Assignment Randomized Trial Comparing Commonly Prescribed and Over the Counter Medications for the Treatment of Insomnia in Adults",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2032-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07689240",
"publication_url": "https://clinicaltrials.gov/study/NCT07689240",
"title": "Phase III Study of Adjuvant Pembrolizumab vs Active Surveillance After Nephrectomy in Patients With Non-Clear Cell Renal-Cell Carcinoma",
"has_exemption": false,
"start_date": "2027-02-10",
"completion_date": "2032-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745076",
"publication_url": "https://clinicaltrials.gov/study/NCT06745076",
"title": "A Multicenter Study PRECISE-HL: Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation in Advanced Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2032-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780111",
"publication_url": "https://clinicaltrials.gov/study/NCT06780111",
"title": "A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2032-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06971939",
"publication_url": "https://clinicaltrials.gov/study/NCT06971939",
"title": "A Phase 4, Multicenter, Open-label Study to Evaluate Long-term Safety and Efficacy of Revakinagene Taroretcel-Lwey (NT-501) Previously Implanted During a Phase 1, Phase 2, or Phase 3 Clinical Study and to Evaluate NT-501 Implanted in Participants Who Underwent the Sham Procedure in a Phase 3 Clinical Study of Macular Telangiectasia Type 2 (MacTel)",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2032-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurotech Pharmaceuticals",
"sponsor_slug": "neurotech-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022678",
"publication_url": "https://clinicaltrials.gov/study/NCT07022678",
"title": "A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections From Oral Organisms in Pediatric Patients With Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-05-26",
"completion_date": "2032-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218887",
"publication_url": "https://clinicaltrials.gov/study/NCT07218887",
"title": "A Phase 1/2, Open-Label, Multicenter, Dose Finding and Dose Expansion Study to Investigate the Safety, Tolerability, and Efficacy of ALXN2350 Gene Therapy in Adult Participants With BAG3 Mutation Associated Dilated Cardiomyopathy",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2032-01-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05789082",
"publication_url": "https://clinicaltrials.gov/study/NCT05789082",
"title": "A Phase Ib/II, Open-Label, Multicenter Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients With Previously Untreated Advanced Or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2023-06-20",
"completion_date": "2032-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07621796",
"publication_url": "https://clinicaltrials.gov/study/NCT07621796",
"title": "Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant (ESTER-DOAC)",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2032-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214688",
"publication_url": "https://clinicaltrials.gov/study/NCT07214688",
"title": "A Phase 2 Study of Fludarabine and Intermediate-dose Total Body Irradiation (800 cGy) Followed by Post-transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2032-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303894",
"publication_url": "https://clinicaltrials.gov/study/NCT07303894",
"title": "Randomized, Multi-dose, Placebo-controlled Phase 2 Trial of Oral Isoquercetin to Reduce Thrombin Generation in Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2032-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07541170",
"publication_url": "https://clinicaltrials.gov/study/NCT07541170",
"title": "A Phase III, Randomized, Open-label Study Evaluating the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Patients With Resected Stage II-III KRAS G12C-Positive Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06770582",
"publication_url": "https://clinicaltrials.gov/study/NCT06770582",
"title": "Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial)",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2032-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686121",
"publication_url": "https://clinicaltrials.gov/study/NCT06686121",
"title": "IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2032-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788912",
"publication_url": "https://clinicaltrials.gov/study/NCT06788912",
"title": "KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2032-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04165070",
"publication_url": "https://clinicaltrials.gov/study/NCT04165070",
"title": "KEYMAKER-U01 Substudy 01A: A Phase 1/2, Umbrella Study With Rolling Arms of Investigational Agents With Pembrolizumab With or Without Chemotherapy in Treatment-Naive Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2032-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05533697",
"publication_url": "https://clinicaltrials.gov/study/NCT05533697",
"title": "Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2022-09-01",
"completion_date": "2032-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057402",
"publication_url": "https://clinicaltrials.gov/study/NCT06057402",
"title": "ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2032-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807281",
"publication_url": "https://clinicaltrials.gov/study/NCT06807281",
"title": "A Phase 3, Multicenter, Long-Term, Open Label Study Evaluating the Safety and Efficacy of Abrocitinib, With or Without Topical Medications Administered to Pediatric Participants Aged 2 Years and Older With Moderate-to-Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2032-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195695",
"publication_url": "https://clinicaltrials.gov/study/NCT07195695",
"title": "Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2032-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227402",
"publication_url": "https://clinicaltrials.gov/study/NCT07227402",
"title": "A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants With Advanced RCC Who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2032-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04774718",
"publication_url": "https://clinicaltrials.gov/study/NCT04774718",
"title": "A Phase I/II, Open-Label, Multicenter, Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors for Whom Prior Treatment Has Proven to be Ineffective or for Whom There is No Satisfactory Treatment Available",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2032-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692712",
"publication_url": "https://clinicaltrials.gov/study/NCT06692712",
"title": "Intrathecal Administration of MELPIDA (AAV9/AP4M1) For Hereditary Spastic Paraplegia Type 50 (SPG50): A Phase 3, Open-Label Trial With Matched Prospective Concurrent Control Arm",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2032-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05143840",
"publication_url": "https://clinicaltrials.gov/study/NCT05143840",
"title": "Asciminib as Initial Therapy With Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia Who do Not Achieve Optimal Response or a Deep Molecular Remission (ALERT CML)",
"has_exemption": false,
"start_date": "2022-04-22",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073821",
"publication_url": "https://clinicaltrials.gov/study/NCT06073821",
"title": "A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2023-11-11",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544798",
"publication_url": "https://clinicaltrials.gov/study/NCT06544798",
"title": "Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia",
"has_exemption": false,
"start_date": "2024-08-02",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788522",
"publication_url": "https://clinicaltrials.gov/study/NCT06788522",
"title": "The Effects of Orexin Antagonism on Fear Extinction in PTSD",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2032-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780098",
"publication_url": "https://clinicaltrials.gov/study/NCT06780098",
"title": "KEYMAKER-U01 Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2032-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731907",
"publication_url": "https://clinicaltrials.gov/study/NCT06731907",
"title": "KEYMAKER-U01 Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-03-30",
"completion_date": "2032-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780085",
"publication_url": "https://clinicaltrials.gov/study/NCT06780085",
"title": "KEYMAKER-U01 Substudy 01H: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2032-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06351592",
"publication_url": "https://clinicaltrials.gov/study/NCT06351592",
"title": "First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ALN-SOD in Participants With Amyotrophic Lateral Sclerosis and SOD1 Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2032-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022483",
"publication_url": "https://clinicaltrials.gov/study/NCT07022483",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy With or Without Radiotherapy as Adjuvant Treatment for HER2-Expressing (IHC 3+/2+) Endometrial Cancer (DESTINY-Endometrial02/ GOG-3122/ ENGOT-en30/GINECO)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05682378",
"publication_url": "https://clinicaltrials.gov/study/NCT05682378",
"title": "An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20 or ORION-19 Studies (VICTORION-PEDS-OLE)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2032-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991556",
"publication_url": "https://clinicaltrials.gov/study/NCT06991556",
"title": "A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2032-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03959085",
"publication_url": "https://clinicaltrials.gov/study/NCT03959085",
"title": "A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy",
"has_exemption": false,
"start_date": "2019-10-31",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06337318",
"publication_url": "https://clinicaltrials.gov/study/NCT06337318",
"title": "Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-10-23",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07110246",
"publication_url": "https://clinicaltrials.gov/study/NCT07110246",
"title": "A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients With BRAF V600 Mutant Low-Grade Gliomas",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07294677",
"publication_url": "https://clinicaltrials.gov/study/NCT07294677",
"title": "CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07718854",
"publication_url": "https://clinicaltrials.gov/study/NCT07718854",
"title": "A Phase 2 Randomized Trial of Sacituzumab Tirumotecan (MK2870) Alone and in Combination With Pembrolizumab in Ovarian Clear Cell Carcinoma Previously Exposed to Immunotherapy",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tufts Medical Center",
"sponsor_slug": "tufts-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07659678",
"publication_url": "https://clinicaltrials.gov/study/NCT07659678",
"title": "CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07682129",
"publication_url": "https://clinicaltrials.gov/study/NCT07682129",
"title": "A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Entrada Therapeutics, Inc.",
"sponsor_slug": "entrada-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07723651",
"publication_url": "https://clinicaltrials.gov/study/NCT07723651",
"title": "Integration of FTT-PET and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07645300",
"publication_url": "https://clinicaltrials.gov/study/NCT07645300",
"title": "LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD (LODESTAR) Trial",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649747",
"publication_url": "https://clinicaltrials.gov/study/NCT06649747",
"title": "A Double-blind, Placebo-controlled, Multi-center Phase II Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral AFA-281 in Patients With Painful Lumbosacral Radiculopathy",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2032-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Afasci Inc",
"sponsor_slug": "afasci-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07572747",
"publication_url": "https://clinicaltrials.gov/study/NCT07572747",
"title": "Aspirin Versus Clopidogrel for Secondary Prevention of Atherosclerotic Cardiovascular Events in Patients With Chronic Coronary Syndrome in the Arabian Gulf Countries: A Randomized, Open-label, Multi-Center Trial by the Gulf Trialists' Collaboration",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2032-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Khalid F Alhabib",
"sponsor_slug": "khalid-f-alhabib",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209111",
"publication_url": "https://clinicaltrials.gov/study/NCT07209111",
"title": "A Phase 2, Open-Label, Multicenter, Tumor-agnostic Study of MK-1084 as Monotherapy and in Combination With Cetuximab, in Participants With KRAS G12C-Mutant, Advanced Solid Tumors (KANDLELIT-014)",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2032-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714085",
"publication_url": "https://clinicaltrials.gov/study/NCT05714085",
"title": "A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2032-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666322",
"publication_url": "https://clinicaltrials.gov/study/NCT06666322",
"title": "Platform Trial For Cryptococcal Meningitis",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2032-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04077099",
"publication_url": "https://clinicaltrials.gov/study/NCT04077099",
"title": "A Phase 1/2 Study of REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2020-01-07",
"completion_date": "2032-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06229210",
"publication_url": "https://clinicaltrials.gov/study/NCT06229210",
"title": "An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2024-01-25",
"completion_date": "2032-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07612254",
"publication_url": "https://clinicaltrials.gov/study/NCT07612254",
"title": "REPEAT: RE-irradiation With a Partial brEast, Accelerated Technique: A Single-Center, Multi-site, Prospective, Phase I/II Clinical Trial",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2032-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04114136",
"publication_url": "https://clinicaltrials.gov/study/NCT04114136",
"title": "A Phase II Clinical Trial of Anti-PD-1 mAb Therapy Alone or With Metabolic Modulators to Reverse Tumor Hypoxia and Immune Dysfunction in Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2020-09-14",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dan Zandberg",
"sponsor_slug": "dan-zandberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04093349",
"publication_url": "https://clinicaltrials.gov/study/NCT04093349",
"title": "Phase 1/2, Dose-escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults With Late-onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-01",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics, Inc.",
"sponsor_slug": "spark-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05031897",
"publication_url": "https://clinicaltrials.gov/study/NCT05031897",
"title": "A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05707949",
"publication_url": "https://clinicaltrials.gov/study/NCT05707949",
"title": "A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 Years of Age With Migraine",
"has_exemption": false,
"start_date": "2023-06-05",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05833763",
"publication_url": "https://clinicaltrials.gov/study/NCT05833763",
"title": "An Open-label, Single-arm, Phase 2 Trial of GlOfitamab anD pIrtobrutinib (LOXo-305) in Patients With Mantle Cell Lymphoma and Prior Exposure to a BTK Inhibitor",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Australasian Leukaemia and Lymphoma Group",
"sponsor_slug": "australasian-leukaemia-and-lymphoma-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07448610",
"publication_url": "https://clinicaltrials.gov/study/NCT07448610",
"title": "Onasemnogene Abeparvovec: ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2032-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140524",
"publication_url": "https://clinicaltrials.gov/study/NCT06140524",
"title": "Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2032-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952504",
"publication_url": "https://clinicaltrials.gov/study/NCT06952504",
"title": "A Phase 3 Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-line Maintenance Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (TroFuse-033/GOG-3119/ENGOT-en29)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2032-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06790693",
"publication_url": "https://clinicaltrials.gov/study/NCT06790693",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2032-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04130997",
"publication_url": "https://clinicaltrials.gov/study/NCT04130997",
"title": "An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2019-11-18",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05630053",
"publication_url": "https://clinicaltrials.gov/study/NCT05630053",
"title": "Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA",
"has_exemption": false,
"start_date": "2023-07-25",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05794321",
"publication_url": "https://clinicaltrials.gov/study/NCT05794321",
"title": "Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy",
"has_exemption": false,
"start_date": "2023-09-28",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06058377",
"publication_url": "https://clinicaltrials.gov/study/NCT06058377",
"title": "Phase III Trial Of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone For Adults With MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer",
"has_exemption": false,
"start_date": "2023-11-27",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06374459",
"publication_url": "https://clinicaltrials.gov/study/NCT06374459",
"title": "A Phase Ib/II Trial of Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773910",
"publication_url": "https://clinicaltrials.gov/study/NCT06773910",
"title": "An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005154",
"publication_url": "https://clinicaltrials.gov/study/NCT07005154",
"title": "A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants With Advanced Prostate Cancer",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07649603",
"publication_url": "https://clinicaltrials.gov/study/NCT07649603",
"title": "Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation: The PREVENT-AF Study II",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05947851",
"publication_url": "https://clinicaltrials.gov/study/NCT05947851",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib (MK-1026) Plus Venetoclax Versus Venetoclax Plus Rituximab in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least 1 Prior Therapy (BELLWAVE-010)",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2032-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07147166",
"publication_url": "https://clinicaltrials.gov/study/NCT07147166",
"title": "Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy: A Randomized Self-Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-03",
"completion_date": "2032-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07722611",
"publication_url": "https://clinicaltrials.gov/study/NCT07722611",
"title": "A Phase 2/3, Randomized, Open-label, Active-comparator-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543) Versus Best Available Therapy in Participants With Polycythemia Vera Who Have an Inadequate Response to or Are Intolerant to Hydroxyurea",
"has_exemption": false,
"start_date": "2026-09-21",
"completion_date": "2032-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07717450",
"publication_url": "https://clinicaltrials.gov/study/NCT07717450",
"title": "TAILORswitch (PADA-2): Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.",
"has_exemption": false,
"start_date": "2026-09-25",
"completion_date": "2032-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "UNICANCER",
"sponsor_slug": "unicancer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04430218",
"publication_url": "https://clinicaltrials.gov/study/NCT04430218",
"title": "Peripheral Interfaces in Amputees for Sensorimotor Integration",
"has_exemption": false,
"start_date": "2020-08-18",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05468359",
"publication_url": "https://clinicaltrials.gov/study/NCT05468359",
"title": "ANGIO-A: Safety and Tolerability of Oral Cyclophosphamide and Sorafenib With Intravenous Bevacizumab With the Addition of Atezolizumab in Pediatric Solid Tumor Patients",
"has_exemption": false,
"start_date": "2022-11-07",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05425615",
"publication_url": "https://clinicaltrials.gov/study/NCT05425615",
"title": "Probing Language Processes Using Transcranial Magnetic Stimulation",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494501",
"publication_url": "https://clinicaltrials.gov/study/NCT06494501",
"title": "The Prevent Coronary Artery Disease Trial",
"has_exemption": false,
"start_date": "2024-09-12",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940739",
"publication_url": "https://clinicaltrials.gov/study/NCT06940739",
"title": "A Phase 1/2, Open-label Study of a Modified Interleukin-2 Fusion Protein (IOV-3001) in Participants With Previously Treated, Unresectable or Metastatic Melanoma Who Will Receive Lifileucel",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445114",
"publication_url": "https://clinicaltrials.gov/study/NCT06445114",
"title": "ULTRA-HPV Using Circulating Tumor DNA to Risk Adapt Post-operative Therapy for HPV Associated Oropharyngeal Cancer",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zachary Zumsteg",
"sponsor_slug": "zachary-zumsteg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389278",
"publication_url": "https://clinicaltrials.gov/study/NCT07389278",
"title": "A Phase 1/2 Study of Pegylated Arginine Deiminase (ADI-PEG 20) Plus Radiotherapy (RT) and Temozolomide (TMZ) in Children, Adolescents, and Young Adults With Newly Diagnosed High-grade Glioma (HGG)",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07721025",
"publication_url": "https://clinicaltrials.gov/study/NCT07721025",
"title": "A Phase 2, Multicenter, Open-label, Randomized, Controlled Study of LX2006 Gene Therapy in Participants With Friedreich Ataxia Cardiomyopathy (SUNRISE-FA 2)",
"has_exemption": false,
"start_date": "2026-06-25",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lexeo Therapeutics",
"sponsor_slug": "lexeo-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07581002",
"publication_url": "https://clinicaltrials.gov/study/NCT07581002",
"title": "A Randomized Phase 2/3 Study Evaluating the Safety and Efficacy of Pivekimab Sunirine (PVEK) in Combination With Venetoclax and Azacitidine in Adult Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible to Receive Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2026-07-22",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07624227",
"publication_url": "https://clinicaltrials.gov/study/NCT07624227",
"title": "The Impact of Cobenfy Maintenance on Cocaine's Effects",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Joshua A. Lile, Ph.D.",
"sponsor_slug": "joshua-a-lile-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07541079",
"publication_url": "https://clinicaltrials.gov/study/NCT07541079",
"title": "A Phase IIIb, Single-Arm, Open-Label Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes (PRO) of Giredestrant in Patients With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06122974",
"publication_url": "https://clinicaltrials.gov/study/NCT06122974",
"title": "A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ReFlow Medical, Inc.",
"sponsor_slug": "reflow-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06900998",
"publication_url": "https://clinicaltrials.gov/study/NCT06900998",
"title": "A Pilot Study on the Effects of Nimodipine on Alcohol Drinking Among Adults Who Are Heavy Alcohol Drinkers",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07681869",
"publication_url": "https://clinicaltrials.gov/study/NCT07681869",
"title": "A Randomized Controlled Study on the Effects of Nimodipine on Alcohol Drinking Among Adults Who Are Heavy Alcohol Drinkers",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07675954",
"publication_url": "https://clinicaltrials.gov/study/NCT07675954",
"title": "A Phase 3, Open-Label, Randomised Controlled Trial to Evaluate a 6-Month \"MDR-END Plus\" Regimen (Bedaquiline, Delamanid, Delpazolid, Levofloxacin and Pyrazinamide) Versus the South African Standard of Care Treatment for Rifampicin-Resistant Tuberculosis",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Seoul National University Hospital",
"sponsor_slug": "seoul-national-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04175431",
"publication_url": "https://clinicaltrials.gov/study/NCT04175431",
"title": "Prostate Specific Membrane Antigen (PSMA) or Fluciclovine (FACBC) PET/CT Site-Directed Therapy of OLigometASTatic Prostate Cancer (P-Flu-BLAST-PC): A Multicenter Study",
"has_exemption": false,
"start_date": "2020-09-30",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06087263",
"publication_url": "https://clinicaltrials.gov/study/NCT06087263",
"title": "Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026942",
"publication_url": "https://clinicaltrials.gov/study/NCT07026942",
"title": "A Phase I/II Clinical Trial Evaluating the Safety and Efficacy of Universal Donor CD33 CAR Natural Killer Cells for Treatment of Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991738",
"publication_url": "https://clinicaltrials.gov/study/NCT06991738",
"title": "Phase 1/2, Open-Label Study of the Safety, Dosimetry and Efficacy of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05076175",
"publication_url": "https://clinicaltrials.gov/study/NCT05076175",
"title": "A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis With an Inadequate Response to Conventional Therapy",
"has_exemption": false,
"start_date": "2022-05-30",
"completion_date": "2032-07-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213830",
"publication_url": "https://clinicaltrials.gov/study/NCT07213830",
"title": "An Open-label, Phase I/II First in Human, Dose Escalation, Optimisation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Participants With Locally Advanced or Metastatic Solid Tumours Who Have Progressed on or After Immune Checkpoint Inhibitor Therapies",
"has_exemption": false,
"start_date": "2026-02-06",
"completion_date": "2032-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05795140",
"publication_url": "https://clinicaltrials.gov/study/NCT05795140",
"title": "A Multi-center, Single Arm, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Iptacopan in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Who Have Completed a Preceding Iptacopan Phase 3 Study in aHUS",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2032-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03033992",
"publication_url": "https://clinicaltrials.gov/study/NCT03033992",
"title": "Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma or Ependymoma, and Feasibility and Efficacy Trial of Optune in Conjunction With Radiation Therapy for Children With Newly Diagnosed DIPG",
"has_exemption": false,
"start_date": "2017-04-04",
"completion_date": "2032-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07634471",
"publication_url": "https://clinicaltrials.gov/study/NCT07634471",
"title": "A Phase 2/3 Randomized, Open-label Study of MK-1045 in Combination With Rituximab in Participants With 1L Follicular Lymphoma",
"has_exemption": false,
"start_date": "2026-06-22",
"completion_date": "2032-07-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05112601",
"publication_url": "https://clinicaltrials.gov/study/NCT05112601",
"title": "A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients With Deficient Mismatch Repair System Recurrent Endometrial Carcinoma",
"has_exemption": false,
"start_date": "2022-06-02",
"completion_date": "2032-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06884865",
"publication_url": "https://clinicaltrials.gov/study/NCT06884865",
"title": "A Phase 2, Two-Part, Randomized, Double-Blind, Active-Controlled Study to Assess the Safety and Tolerability of Enekinragene Inzadenovec (PCRX-201) in Subjects With Painful Osteoarthritis of the Knee",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2032-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pacira Pharmaceuticals, Inc",
"sponsor_slug": "pacira-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07161544",
"publication_url": "https://clinicaltrials.gov/study/NCT07161544",
"title": "An Open-label, Multicenter, Two Part, Ascending Dose Followed by a Controlled Trial to Assess the Safety and Efficacy of a Subretinal Administration of AAVB-039 in Participants With Stargardt Disease (STGD1) (CELESTE)",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2032-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AAVantgarde Bio Srl",
"sponsor_slug": "aavantgarde-bio-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07355205",
"publication_url": "https://clinicaltrials.gov/study/NCT07355205",
"title": "A Phase Ib/II, Single-Center, Open-Label Study of First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (FLINN)",
"has_exemption": false,
"start_date": "2026-07-07",
"completion_date": "2032-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07550517",
"publication_url": "https://clinicaltrials.gov/study/NCT07550517",
"title": "A Phase II Non-blinded Randomized Study Comparing External Beam Radiotherapy (EBRT), 177Lu-PSMA-617, and Short Term Androgen Deprivation Therapy (ADT) Versus EBRT and Long Term ADT in Men With High Risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2032-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190300",
"publication_url": "https://clinicaltrials.gov/study/NCT07190300",
"title": "TulmiSTAR-02: A Two-part Phase I Dose Escalation Study of Tulmimetostat (DZR123) in Combination With Darolutamide or Abiraterone Followed by Open-label, Randomized, Phase II Dose Expansion Study to Assess the Safety and Efficacy of Tulmimetostat in Combination With Darolutamide Versus Darolutamide Alone in Patients With Metastatic Hormone-sensitive Prostate Cancer",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2032-08-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05212246",
"publication_url": "https://clinicaltrials.gov/study/NCT05212246",
"title": "CSP #2019 - Basal Cell Carcinoma Chemoprevention Trial (B3C)",
"has_exemption": false,
"start_date": "2026-08-03",
"completion_date": "2032-08-03",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07567469",
"publication_url": "https://clinicaltrials.gov/study/NCT07567469",
"title": "A Phase 1/2 Open-Label, Safety and Efficacy Study of Neoadjuvant Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) and Cemiplimab Alone Followed by Adjuvant Fianlimab in Combination With Cemiplimab in Pediatric and Young Adult Participants With Recurrent or Progressive High-Grade Glioma or Pediatric and Adult Participants With Recurrent or Progressive Posterior Fossa-A Ependymoma",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-08-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03579901",
"publication_url": "https://clinicaltrials.gov/study/NCT03579901",
"title": "Study of the Safety and Effectiveness of the Motiva Implants® Silicone Gel-Filled Breast Implants SmoothSilk® in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction, and Revision Surgery",
"has_exemption": false,
"start_date": "2018-04-06",
"completion_date": "2032-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487599",
"publication_url": "https://clinicaltrials.gov/study/NCT05487599",
"title": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2032-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07645326",
"publication_url": "https://clinicaltrials.gov/study/NCT07645326",
"title": "A Pragmatic Phase 2 Trial of Risk-Adapted Treatment Approaches Including Treatment De-escalation to Minimize Adverse Effects of Hormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Georgetown University",
"sponsor_slug": "georgetown-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05496959",
"publication_url": "https://clinicaltrials.gov/study/NCT05496959",
"title": "177-Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (Lunar)",
"has_exemption": false,
"start_date": "2022-09-02",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991335",
"publication_url": "https://clinicaltrials.gov/study/NCT06991335",
"title": "Deep Brain Stimulation (DBS) of the Ventral Capsule Ventral Striatum (VC/VS) for the Treatment of Apathy in Parkinson's Disease (PD)",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nora Vanegas",
"sponsor_slug": "nora-vanegas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07683026",
"publication_url": "https://clinicaltrials.gov/study/NCT07683026",
"title": "Adaptive Platform Trial to Delay Progression From Normoglycemia to Dysglycemia in Presymptomatic Type 1 Diabetes: Golimumab Substudy",
"has_exemption": false,
"start_date": "2026-08-08",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07717411",
"publication_url": "https://clinicaltrials.gov/study/NCT07717411",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2032-09-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07585266",
"publication_url": "https://clinicaltrials.gov/study/NCT07585266",
"title": "A Phase 3, Randomized, Multicenter, Open-Label Study of Velzatinib (GSK6042981) Versus Imatinib in Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST)",
"has_exemption": false,
"start_date": "2026-07-10",
"completion_date": "2032-09-06",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136559",
"publication_url": "https://clinicaltrials.gov/study/NCT06136559",
"title": "A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2032-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04589845",
"publication_url": "https://clinicaltrials.gov/study/NCT04589845",
"title": "Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial",
"has_exemption": false,
"start_date": "2021-01-18",
"completion_date": "2032-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02984761",
"publication_url": "https://clinicaltrials.gov/study/NCT02984761",
"title": "CSP #2005 - Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR)",
"has_exemption": false,
"start_date": "2017-04-13",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04687020",
"publication_url": "https://clinicaltrials.gov/study/NCT04687020",
"title": "Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04910685",
"publication_url": "https://clinicaltrials.gov/study/NCT04910685",
"title": "A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis",
"has_exemption": false,
"start_date": "2021-11-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Blueprint Medicines Corporation",
"sponsor_slug": "blueprint-medicines-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06574126",
"publication_url": "https://clinicaltrials.gov/study/NCT06574126",
"title": "Phase II Open-Label, Single Arm, Multicenter Study of Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma (GEM-CAR-HiRiSMM)",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05563948",
"publication_url": "https://clinicaltrials.gov/study/NCT05563948",
"title": "Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07674901",
"publication_url": "https://clinicaltrials.gov/study/NCT07674901",
"title": "A Superiority Randomized Controlled Trial of Daily Knee Sleeve Use Versus No Use in Older Adults With Chronic Knee Pain",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Margaret L Gourlay, MD, MPH",
"sponsor_slug": "margaret-l-gourlay-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07388524",
"publication_url": "https://clinicaltrials.gov/study/NCT07388524",
"title": "Evaluating Adjuvant Atezolizumab or Atezolizumab and Hyaluronidase-TQJS to Prevent Recurrence in Stage I Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase III Trial (AASI-NSCLC)",
"has_exemption": false,
"start_date": "2027-03-02",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05460000",
"publication_url": "https://clinicaltrials.gov/study/NCT05460000",
"title": "A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy (N-Plus)",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2032-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "North Eastern German Society of Gynaecological Oncology",
"sponsor_slug": "north-eastern-german-society-of-gynaecological-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953778",
"publication_url": "https://clinicaltrials.gov/study/NCT06953778",
"title": "CSP #2037S - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-S) Trial",
"has_exemption": false,
"start_date": "2027-03-08",
"completion_date": "2032-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953726",
"publication_url": "https://clinicaltrials.gov/study/NCT06953726",
"title": "CSP #2037T - Veterans Affairs Learning Health System Initiative to Assess Novel Screening vs. Usual Care and Treatment With Apixaban vs. Rivaroxaban in Veterans With Atrial Fibrillation (VALIANT-AF-T) Trial",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2032-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05521997",
"publication_url": "https://clinicaltrials.gov/study/NCT05521997",
"title": "Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2032-10-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04576130",
"publication_url": "https://clinicaltrials.gov/study/NCT04576130",
"title": "A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Who Receive Complete Revascularization",
"has_exemption": false,
"start_date": "2020-10-12",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rigshospitalet, Denmark",
"sponsor_slug": "rigshospitalet-denmark",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508009",
"publication_url": "https://clinicaltrials.gov/study/NCT05508009",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRαβ+ T-cell/CD19+ B-cell Depletion for Patients Who Will Receive a Kidney Transplant (KT) From the Same HSCT/KT Donor",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alice Bertaina",
"sponsor_slug": "alice-bertaina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06235697",
"publication_url": "https://clinicaltrials.gov/study/NCT06235697",
"title": "Androgen Suppression Combined With Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Brachytherapy Boost in Patients With Unfavourable Risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-25",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915025",
"publication_url": "https://clinicaltrials.gov/study/NCT06915025",
"title": "A Randomized Phase 3 Trial Evaluating the Safety & Efficacy of IP IMNN-001 Administered in Combination w/ Standard Neoadjuvant & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Imunon",
"sponsor_slug": "imunon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07605416",
"publication_url": "https://clinicaltrials.gov/study/NCT07605416",
"title": "Quadruplet Induction Followed by Teclistamab Consolidation and Doublet Maintenance in Patients With Primary Plasma Cell Leukemia: The QUANTUM Trial",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2032-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03897881",
"publication_url": "https://clinicaltrials.gov/study/NCT03897881",
"title": "A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma (KEYNOTE- 942)",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05283720",
"publication_url": "https://clinicaltrials.gov/study/NCT05283720",
"title": "Phase 1b/2, Open-Label Study to Evaluate Safety and Tolerability of Epcoritamab in Combination With Anti-Neoplastic Agents in Subjects With Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06974786",
"publication_url": "https://clinicaltrials.gov/study/NCT06974786",
"title": "Frontline T-cell Engager vs Autologous Stem Cell Transplant and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma (FASTER)",
"has_exemption": false,
"start_date": "2025-08-08",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154550",
"publication_url": "https://clinicaltrials.gov/study/NCT07154550",
"title": "A Randomized Controlled Trial Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216235",
"publication_url": "https://clinicaltrials.gov/study/NCT07216235",
"title": "A Phase 3b/4, Multicenter, Parallel-Group, Double-Blind, Placebo Controlled, Two-Arm, Long-Term Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium on Clinical Outcomes in Participants With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07456865",
"publication_url": "https://clinicaltrials.gov/study/NCT07456865",
"title": "Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187206",
"publication_url": "https://clinicaltrials.gov/study/NCT07187206",
"title": "Safety and Efficacy of FETO in CDH Phase III",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2032-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07238452",
"publication_url": "https://clinicaltrials.gov/study/NCT07238452",
"title": "Optimising Pacing Therapy, Integrated Medical Therapy, and Catheter AbLation for Atrial Fibrillation in Heart Failure Trial",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2032-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of British Columbia",
"sponsor_slug": "university-of-british-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06910124",
"publication_url": "https://clinicaltrials.gov/study/NCT06910124",
"title": "Alpe d'Huez Study: A Parallel Two-Cohort Study of Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2032-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Dickran Kazandjian, MD",
"sponsor_slug": "dickran-kazandjian-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07554339",
"publication_url": "https://clinicaltrials.gov/study/NCT07554339",
"title": "A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Study of MK-1084 Plus Durvalumab Versus Placebo Plus Durvalumab in Participants With Locally Advanced, Unresected KRAS G12C-Mutant Non-Small Cell Lung Cancer Without Disease Progression Following Definitive Platinum-Based Chemoradiotherapy (KANDLELIT-015)",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2032-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06385080",
"publication_url": "https://clinicaltrials.gov/study/NCT06385080",
"title": "A Phase 1b/2, Open-label Study of Amivantamab Monotherapy and Amivantamab in Addition to Other Therapeutic Agents in Participants With Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2032-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03340506",
"publication_url": "https://clinicaltrials.gov/study/NCT03340506",
"title": "Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study",
"has_exemption": false,
"start_date": "2018-01-26",
"completion_date": "2032-12-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04877288",
"publication_url": "https://clinicaltrials.gov/study/NCT04877288",
"title": "A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications",
"has_exemption": false,
"start_date": "2021-07-21",
"completion_date": "2032-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01306019",
"publication_url": "https://clinicaltrials.gov/study/NCT01306019",
"title": "Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency",
"has_exemption": false,
"start_date": "2012-09-25",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03520660",
"publication_url": "https://clinicaltrials.gov/study/NCT03520660",
"title": "Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents",
"has_exemption": false,
"start_date": "2018-10-19",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04423211",
"publication_url": "https://clinicaltrials.gov/study/NCT04423211",
"title": "Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)",
"has_exemption": false,
"start_date": "2020-10-08",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04880876",
"publication_url": "https://clinicaltrials.gov/study/NCT04880876",
"title": "A Phase 3, Long-term Safety Study of Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)",
"has_exemption": false,
"start_date": "2021-08-13",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04597359",
"publication_url": "https://clinicaltrials.gov/study/NCT04597359",
"title": "A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers",
"has_exemption": false,
"start_date": "2021-10-05",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659082",
"publication_url": "https://clinicaltrials.gov/study/NCT05659082",
"title": "Cognition and Magnetic Resonance Imaging After Psychiatric Neurosurgery for Intractable Obsessive-Compulsive Disorder- Phase 2",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Butler Hospital",
"sponsor_slug": "butler-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06019832",
"publication_url": "https://clinicaltrials.gov/study/NCT06019832",
"title": "Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jacob M. Elkins",
"sponsor_slug": "jacob-m-elkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06714604",
"publication_url": "https://clinicaltrials.gov/study/NCT06714604",
"title": "Standard Versus Prolonged Neoadjuvant (Conversion) Chemotherapy to Prolong Survival of Patients With Borderline and Locally Advanced Pancreatic Cancer: a Phase III Randomized Controlled",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sahlgrenska University Hospital",
"sponsor_slug": "sahlgrenska-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05975593",
"publication_url": "https://clinicaltrials.gov/study/NCT05975593",
"title": "MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)",
"has_exemption": false,
"start_date": "2024-01-11",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06325709",
"publication_url": "https://clinicaltrials.gov/study/NCT06325709",
"title": "Phase 1/2 Trial of Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-linked Chronic Granulomatous Disease",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06477939",
"publication_url": "https://clinicaltrials.gov/study/NCT06477939",
"title": "Phase III Randomized Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients to Evaluate Efficacy and Safety",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Cancerologie Strasbourg Europe",
"sponsor_slug": "institut-de-cancerologie-strasbourg-europe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849258",
"publication_url": "https://clinicaltrials.gov/study/NCT06849258",
"title": "A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of The FloStent in Men Suffering From Benign Prostatic Hyperplasia Symptoms",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rivermark Medical",
"sponsor_slug": "rivermark-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288203",
"publication_url": "https://clinicaltrials.gov/study/NCT07288203",
"title": "A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Melanoma",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07401316",
"publication_url": "https://clinicaltrials.gov/study/NCT07401316",
"title": "Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447557",
"publication_url": "https://clinicaltrials.gov/study/NCT07447557",
"title": "A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of a Single Dose of ELP-02 Delivered Via Lumbar Intrathecal Administration in Charcot-Marie-Tooth-4J (CMT4J)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215416",
"publication_url": "https://clinicaltrials.gov/study/NCT07215416",
"title": "A Phase 1/2 Study of Antisense Oligonucleotide Therapy for Treatment of Ataxia-Telangiectasia",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Timothy Yu",
"sponsor_slug": "timothy-yu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07681778",
"publication_url": "https://clinicaltrials.gov/study/NCT07681778",
"title": "A Phase 1b/2a Open-Label, Dose-Exploration Study to Investigate the Safety and Tolerability of Subretinally Injected OPGx-RDH12 Administered in Participants With Leber Congenital Amaurosis With Autosomal-Recessive Retinol Dehydrogenase 12 Mutations",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Opus Genetics, Inc",
"sponsor_slug": "opus-genetics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07691970",
"publication_url": "https://clinicaltrials.gov/study/NCT07691970",
"title": "ROSY-S: Rollover Study for Participants Who Have Completed a Previous Study With Anifrolumab (Saphnelo) and Are Assessed by the Investigator to Clinically Benefit From Continued Treatment",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06008717",
"publication_url": "https://clinicaltrials.gov/study/NCT06008717",
"title": "A Prospective, Randomized Feasibility Clinical Trial Evaluating Bilateral Stimulation of the Dorsolateral Region of the Subthalamic Nucleus Receiving Hyperdirect (M1/SMA) Input in Subjects With Early-Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mallory Hacker",
"sponsor_slug": "mallory-hacker",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06010030",
"publication_url": "https://clinicaltrials.gov/study/NCT06010030",
"title": "A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052618",
"publication_url": "https://clinicaltrials.gov/study/NCT06052618",
"title": "Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322263",
"publication_url": "https://clinicaltrials.gov/study/NCT07322263",
"title": "Intravesical Gemcitabine and Docetaxel for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study (GEMDOCE-BU)",
"has_exemption": false,
"start_date": "2026-04-10",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael A. O'Donnell",
"sponsor_slug": "michael-a-odonnell",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07630168",
"publication_url": "https://clinicaltrials.gov/study/NCT07630168",
"title": "Timing of Immunotherapy and Effective Administration (TIMED): Effects of Infusion Timing on Treatment Response in Solid Tumors",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876142",
"publication_url": "https://clinicaltrials.gov/study/NCT06876142",
"title": "A Phase 1b/2 Study of Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma (RRMM)",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224672",
"publication_url": "https://clinicaltrials.gov/study/NCT07224672",
"title": "A Phase 2, Open-label, Randomized, Dose Optimization Study Evaluating the Efficacy and Safety of Belantamab Mafodotin Administered in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain Amyloidosis (ALANIS)",
"has_exemption": false,
"start_date": "2026-06-24",
"completion_date": "2033-01-12",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07252739",
"publication_url": "https://clinicaltrials.gov/study/NCT07252739",
"title": "KEYMAKER-U01 Substudy 01J: A Randomized Phase 2 Umbrella Study With Rolling Arms of Investigational Agents for First-line Treatment of Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2033-01-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07250802",
"publication_url": "https://clinicaltrials.gov/study/NCT07250802",
"title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2033-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05955508",
"publication_url": "https://clinicaltrials.gov/study/NCT05955508",
"title": "Phase 2 Study of Linvoseltamab in Patients With Smoldering Multiple Myeloma at High Risk of Progression to Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2033-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07456891",
"publication_url": "https://clinicaltrials.gov/study/NCT07456891",
"title": "An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Remibrutinib Study and Are Judged by the Investigator to Benefit From Continued Treatment With Remibrutinib.",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2033-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03003299",
"publication_url": "https://clinicaltrials.gov/study/NCT03003299",
"title": "A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve",
"has_exemption": false,
"start_date": "2017-01-05",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06048159",
"publication_url": "https://clinicaltrials.gov/study/NCT06048159",
"title": "TACS for the Recovery of Phonological STM After Stroke",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07232030",
"publication_url": "https://clinicaltrials.gov/study/NCT07232030",
"title": "Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure (BENEFIT-HF)",
"has_exemption": false,
"start_date": "2026-04-24",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CVRx, Inc.",
"sponsor_slug": "cvrx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07383441",
"publication_url": "https://clinicaltrials.gov/study/NCT07383441",
"title": "Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195734",
"publication_url": "https://clinicaltrials.gov/study/NCT07195734",
"title": "A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients With Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery (NEOPOLIS)",
"has_exemption": false,
"start_date": "2026-04-24",
"completion_date": "2033-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05442567",
"publication_url": "https://clinicaltrials.gov/study/NCT05442567",
"title": "A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2033-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07354074",
"publication_url": "https://clinicaltrials.gov/study/NCT07354074",
"title": "A Phase II, Multicenter, Open-label, Single Arm Study to Evaluate the Safety and Efficacy of Asciminib in Pediatric Participants Newly Diagnosed or Previously Treated With Philadelphia Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) With or Without Known T315I Mutation",
"has_exemption": false,
"start_date": "2026-04-28",
"completion_date": "2033-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318558",
"publication_url": "https://clinicaltrials.gov/study/NCT07318558",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) Maintenance Treatment With or Without Bevacizumab Versus Standard of Care in Participants With Newly Diagnosed Advanced Non-HRD Positive Ovarian Cancer Following First-line Platinum-based Chemotherapy (TroFuse-021/ENGOTov85/GOG-3102)",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2033-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06215716",
"publication_url": "https://clinicaltrials.gov/study/NCT06215716",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis",
"has_exemption": false,
"start_date": "2023-12-01",
"completion_date": "2033-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223697",
"publication_url": "https://clinicaltrials.gov/study/NCT07223697",
"title": "An Extension Study To Evaluate the Long-Term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Atopic Dermatitis Who Participated in Previous Afimkibart Clinical Trials",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2033-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07644312",
"publication_url": "https://clinicaltrials.gov/study/NCT07644312",
"title": "Feasibility and Phase 2a Study of Relatlimab and Nivolumab (Opdualag™) in Adolescent and Young Adult Patients Newly Diagnosed With Replication Repair Deficient High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG)",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2033-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966700",
"publication_url": "https://clinicaltrials.gov/study/NCT06966700",
"title": "A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2033-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03761108",
"publication_url": "https://clinicaltrials.gov/study/NCT03761108",
"title": "Phase 1/2 FIH Study of REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2019-01-23",
"completion_date": "2033-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05786066",
"publication_url": "https://clinicaltrials.gov/study/NCT05786066",
"title": "The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929768",
"publication_url": "https://clinicaltrials.gov/study/NCT05929768",
"title": "Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952803",
"publication_url": "https://clinicaltrials.gov/study/NCT06952803",
"title": "A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients With BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (EvoPAR-Prostate02).",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007065",
"publication_url": "https://clinicaltrials.gov/study/NCT07007065",
"title": "A Randomized, Controlled, Partially Masked, Phase 3b Study to Assess the Injection Burden, Efficacy, Safety, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) in a Real-World Context in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05705453",
"publication_url": "https://clinicaltrials.gov/study/NCT05705453",
"title": "Epidural Stimulation After Neurologic Damage: Long-Term Outcomes",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2033-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237269",
"publication_url": "https://clinicaltrials.gov/study/NCT07237269",
"title": "Abiraterone/Prednisone + Standard ADT vs Standard ADT for Prostate Cancer Patients With PSMA-Positive Conventional Imaging Negative Pelvic Lymphadenopathy",
"has_exemption": false,
"start_date": "2026-04-03",
"completion_date": "2033-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730036",
"publication_url": "https://clinicaltrials.gov/study/NCT05730036",
"title": "An Open-label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti- BCMA x Anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients With Relapsed/Refractory Multiple Myeloma (LINKER-MM3)",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2033-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985915",
"publication_url": "https://clinicaltrials.gov/study/NCT05985915",
"title": "A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjögren's Syndrome",
"has_exemption": false,
"start_date": "2023-10-27",
"completion_date": "2033-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07660172",
"publication_url": "https://clinicaltrials.gov/study/NCT07660172",
"title": "A Phase 2, Open-label, Single-arm Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary Immune Thrombocytopenia Who Had an Insufficient Response to or Relapsed After First-line Corticosteroid Treatment (VAYHIT-P).",
"has_exemption": false,
"start_date": "2027-02-08",
"completion_date": "2033-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05718817",
"publication_url": "https://clinicaltrials.gov/study/NCT05718817",
"title": "A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy",
"has_exemption": false,
"start_date": "2023-04-25",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xenon Pharmaceuticals Inc.",
"sponsor_slug": "xenon-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05505643",
"publication_url": "https://clinicaltrials.gov/study/NCT05505643",
"title": "COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01796795",
"publication_url": "https://clinicaltrials.gov/study/NCT01796795",
"title": "A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.",
"has_exemption": false,
"start_date": "2030-09-30",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "G&E Herbal Biotechnology Co., LTD",
"sponsor_slug": "ge-herbal-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899673",
"publication_url": "https://clinicaltrials.gov/study/NCT05899673",
"title": "A Phase 3, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Fazirsiran in Participants With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2033-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286292",
"publication_url": "https://clinicaltrials.gov/study/NCT07286292",
"title": "A Phase 2, Single Arm, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Vorasidenib in Pediatric Participants Aged 12 to < 18 Years Old With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2033-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Recherches Internationales Servier (I.R.I.S.)",
"sponsor_slug": "institut-de-recherches-internationales-servier-iris",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06623422",
"publication_url": "https://clinicaltrials.gov/study/NCT06623422",
"title": "A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009)",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2033-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145400",
"publication_url": "https://clinicaltrials.gov/study/NCT05145400",
"title": "Phase 2 Study of Isatuximab Plus Lenalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2022-02-18",
"completion_date": "2033-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465199",
"publication_url": "https://clinicaltrials.gov/study/NCT06465199",
"title": "A Phase I/II Study Using Eflornithine (DFMO) and AMXT 1501 for Relapsed and Refractory Neuroblastoma, CNS Tumors, and Sarcomas",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2033-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07520006",
"publication_url": "https://clinicaltrials.gov/study/NCT07520006",
"title": "An Open-label, Multicenter Phase 1b/2 Study to Evaluate the Safety and Efficacy of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2033-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nurix Therapeutics, Inc.",
"sponsor_slug": "nurix-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02339571",
"publication_url": "https://clinicaltrials.gov/study/NCT02339571",
"title": "Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma",
"has_exemption": false,
"start_date": "2015-11-23",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04307576",
"publication_url": "https://clinicaltrials.gov/study/NCT04307576",
"title": "ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)",
"has_exemption": false,
"start_date": "2020-07-13",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mats Heyman",
"sponsor_slug": "mats-heyman",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05257083",
"publication_url": "https://clinicaltrials.gov/study/NCT05257083",
"title": "A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting European Myeloma Network",
"sponsor_slug": "stichting-european-myeloma-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05565105",
"publication_url": "https://clinicaltrials.gov/study/NCT05565105",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Leukemia or Lymphoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Guenther Koehne",
"sponsor_slug": "guenther-koehne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05617625",
"publication_url": "https://clinicaltrials.gov/study/NCT05617625",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Guenther Koehne",
"sponsor_slug": "guenther-koehne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236724",
"publication_url": "https://clinicaltrials.gov/study/NCT06236724",
"title": "Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2033-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07620392",
"publication_url": "https://clinicaltrials.gov/study/NCT07620392",
"title": "An Extension Study to Evaluate the Long-term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Rheumatoid Arthritis Who Participated in Previous Afimkibart Clinical Trials",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2033-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060807",
"publication_url": "https://clinicaltrials.gov/study/NCT07060807",
"title": "An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2033-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05803941",
"publication_url": "https://clinicaltrials.gov/study/NCT05803941",
"title": "A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2033-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07701993",
"publication_url": "https://clinicaltrials.gov/study/NCT07701993",
"title": "A Phase 3, Double-blind, Randomized, Placebo Controlled, 2-arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Injection in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (NEBULA-1)",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2033-07-25",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393282",
"publication_url": "https://clinicaltrials.gov/study/NCT07393282",
"title": "A Phase 3, Randomized, Open-Label Study of Linvoseltamab Versus Daratumumab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2033-07-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04510597",
"publication_url": "https://clinicaltrials.gov/study/NCT04510597",
"title": "Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)",
"has_exemption": false,
"start_date": "2021-03-08",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015853",
"publication_url": "https://clinicaltrials.gov/study/NCT07015853",
"title": "IIT2024-02-SHIAO-ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephen Shiao",
"sponsor_slug": "stephen-shiao",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07510334",
"publication_url": "https://clinicaltrials.gov/study/NCT07510334",
"title": "Phase 2 Clinical Evaluation of Combination Immunotherapy for Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2033-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04984291",
"publication_url": "https://clinicaltrials.gov/study/NCT04984291",
"title": "Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2021-07-28",
"completion_date": "2033-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01736592",
"publication_url": "https://clinicaltrials.gov/study/NCT01736592",
"title": "An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration",
"has_exemption": false,
"start_date": "2012-12-14",
"completion_date": "2033-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07579910",
"publication_url": "https://clinicaltrials.gov/study/NCT07579910",
"title": "A Phase 3, Randomized, Single-blind, Parallel Group, Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebroventricular Tralesinidase Alfa Treatment Compared to Standard of Care in Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2033-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spruce Biosciences",
"sponsor_slug": "spruce-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07326592",
"publication_url": "https://clinicaltrials.gov/study/NCT07326592",
"title": "A Phase 4, Multicenter, Double-blind, Study to Investigate the Efficacy, Safety, and Tolerability of 3 Active Doses of Respreeza® / Zemaira® Weekly Intravenous Infusions Administered Over 3 Years as Longterm Maintenance Therapy in Adult Subjects With Emphysema Related to Alpha1 Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2033-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387926",
"publication_url": "https://clinicaltrials.gov/study/NCT07387926",
"title": "Open-label, Phase I/II Study to Evaluate Safety and Efficacy of Asciminib With Chemotherapy Followed by Asciminib Plus Blinatumomab in Pediatric, Adolescent, and Young Adults With Relapsed or Refractory BCR::ABL1-positive (Philadelphia Positive, Ph+) or BCR::ABL1-like (Ph-like) ALL",
"has_exemption": false,
"start_date": "2026-07-05",
"completion_date": "2033-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06055712",
"publication_url": "https://clinicaltrials.gov/study/NCT06055712",
"title": "Antibiotic Prophylaxis in Pediatric Open Fractures",
"has_exemption": false,
"start_date": "2023-09-11",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192432",
"publication_url": "https://clinicaltrials.gov/study/NCT07192432",
"title": "A Phase 1/2, First-in-Human Study of VNX-202 Gene Therapy in Patients With HER2-Positive Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vironexis Biotherapeutics Inc.",
"sponsor_slug": "vironexis-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07455851",
"publication_url": "https://clinicaltrials.gov/study/NCT07455851",
"title": "A FIH Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN17372, an Anti-GPRC5D x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07624513",
"publication_url": "https://clinicaltrials.gov/study/NCT07624513",
"title": "Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2033-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07570173",
"publication_url": "https://clinicaltrials.gov/study/NCT07570173",
"title": "A Phase 2/3, Randomized, Open-Label, Comparison Study of MK-1045 Versus Blinatumomab in Participants With Relapsed or Refractory CD19+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2033-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07080905",
"publication_url": "https://clinicaltrials.gov/study/NCT07080905",
"title": "Phase 3, Open-label, Single-dose, Multicenter Study Investigating Efficacy, Safety, and Tolerability of CSL222 (Etranacogene Dezaparvovec) Administered to Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2033-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04636190",
"publication_url": "https://clinicaltrials.gov/study/NCT04636190",
"title": "A Retrospectively Enrolled and Prospectively Followed, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon All-Polyethylene Tibia",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05967351",
"publication_url": "https://clinicaltrials.gov/study/NCT05967351",
"title": "A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05994235",
"publication_url": "https://clinicaltrials.gov/study/NCT05994235",
"title": "A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-11-01",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06339320",
"publication_url": "https://clinicaltrials.gov/study/NCT06339320",
"title": "Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05660408",
"publication_url": "https://clinicaltrials.gov/study/NCT05660408",
"title": "RNA PRIME - RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03755739",
"publication_url": "https://clinicaltrials.gov/study/NCT03755739",
"title": "A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2018-11-01",
"completion_date": "2033-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06368817",
"publication_url": "https://clinicaltrials.gov/study/NCT06368817",
"title": "A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2033-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669247",
"publication_url": "https://clinicaltrials.gov/study/NCT06669247",
"title": "A First-in-Human (FIH) Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN7945, an Anti-CD38 x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-12-11",
"completion_date": "2033-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03706027",
"publication_url": "https://clinicaltrials.gov/study/NCT03706027",
"title": "Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Prospective Randomized Phase II Study",
"has_exemption": false,
"start_date": "2018-12-15",
"completion_date": "2033-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07709000",
"publication_url": "https://clinicaltrials.gov/study/NCT07709000",
"title": "A Phase 2, Open-label, Multicenter Study to Determine the Safety, Tolerability, and Efficacy of MK-1045 in Participants With Hematologic Malignancies",
"has_exemption": false,
"start_date": "2026-08-21",
"completion_date": "2033-11-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04742634",
"publication_url": "https://clinicaltrials.gov/study/NCT04742634",
"title": "A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant",
"has_exemption": false,
"start_date": "2022-05-12",
"completion_date": "2033-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05071937",
"publication_url": "https://clinicaltrials.gov/study/NCT05071937",
"title": "Phase ll Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Talazoparib, in Patients With Recurrent Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-04-21",
"completion_date": "2033-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander B Olawaiye, MD",
"sponsor_slug": "alexander-b-olawaiye-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058077",
"publication_url": "https://clinicaltrials.gov/study/NCT07058077",
"title": "An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants With Heterozygous Familial Hypercholesterolemia",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2033-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06101277",
"publication_url": "https://clinicaltrials.gov/study/NCT06101277",
"title": "Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2033-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987449",
"publication_url": "https://clinicaltrials.gov/study/NCT05987449",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2033-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05642195",
"publication_url": "https://clinicaltrials.gov/study/NCT05642195",
"title": "Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2033-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04513717",
"publication_url": "https://clinicaltrials.gov/study/NCT04513717",
"title": "Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04754087",
"publication_url": "https://clinicaltrials.gov/study/NCT04754087",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the G7 Acetabular System With Vivacit-E and Longevity Highly Crosslinked Polyethylene (HXLPE) Liners & Instrumentation",
"has_exemption": false,
"start_date": "2021-07-07",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06103669",
"publication_url": "https://clinicaltrials.gov/study/NCT06103669",
"title": "Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220902",
"publication_url": "https://clinicaltrials.gov/study/NCT07220902",
"title": "Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial \"LEVMag Trial\"",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nebraska Methodist Health System",
"sponsor_slug": "nebraska-methodist-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321847",
"publication_url": "https://clinicaltrials.gov/study/NCT07321847",
"title": "Intratumoral Injection of IP-001 Following Standard-of-care Complete Hepatic Tumor Ablation in Patients With Liver-only Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunophotonics, Inc.",
"sponsor_slug": "immunophotonics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07549698",
"publication_url": "https://clinicaltrials.gov/study/NCT07549698",
"title": "A Phase 1/2 Dose Evaluation Trial of the Safety and Preliminary Efficacy of Anti CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07685028",
"publication_url": "https://clinicaltrials.gov/study/NCT07685028",
"title": "LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A",
"has_exemption": false,
"start_date": "2026-10-06",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07689812",
"publication_url": "https://clinicaltrials.gov/study/NCT07689812",
"title": "A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Continuous Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07700758",
"publication_url": "https://clinicaltrials.gov/study/NCT07700758",
"title": "LIGHTBEAM-U01 Substudy 01E: A Phase 2 Substudy to Evaluate the Safety and Efficacy of Belzutifan in Participants With Solid Tumors",
"has_exemption": false,
"start_date": "2026-11-23",
"completion_date": "2034-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}